ICU Medical, Inc.(ICUI)Earnings, Financials & Key RatiosICU Medical, Inc. (ICUI) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to achieve consistent profitability, evidenced by a 2026Q1 operating margin of only 5.8%, suggests that integration risks continue to outweigh potential upside.
ICU Medical, Inc. (ICUI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
ICU Medical, Inc. (ICUI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $1.97vs $1.78+10.7% | $526Mvs $521M+1.0% |
| Q1 2026 | Feb 19, 2026 | $1.91vs $1.68+13.7% | $536Mvs $531M+1.0% |
| Q4 2025 | Nov 6, 2025 | $2.03vs $1.43+42.0% | $537Mvs $511M+5.0% |
| Q3 2025 | Aug 7, 2025 | $2.10vs $1.44+45.8% | $549Mvs $511M+7.3% |
Recent stock market news and headlines for ICU Medical, Inc. (ICUI)
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Medline (MDLN). But which of these two companies is the best option for those looking for undervalued stocks?
Key metrics vs top competitors for ICU Medical, Inc. (ICUI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $148.46 | $3.71B | 5049.66 | -6.38% | 0.03% | 0.04% | — | |
| $152.90 | $55.39B | 26.23 | 8.23% | 5.33% | 4.54% | — | |
| $43.06 | $64B | 22.20 | 19.87% | 17.23% | 14.67% | — | |
| $94.57 | $3.25B | 32.72 | 7.57% | 7.67% | 8.23% | — | |
| $40.54 | $3.35B | 17.03 | 1.34% | 10.75% | 7.65% | — | |
| $15.78 | $1.8B | -12.93 | 8.28% | -25.66% | -50.82% | — |
ICU Medical, Inc. (ICUI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ICU Medical, Inc. (ICUI) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 18, 2026·SEC
May 7, 2026·SEC
Feb 20, 2026·SEC
Get notified when ICUI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ICU Medical, Inc. (ICUI) stock FAQ — growth, dividends, profitability & financials explained
ICU Medical, Inc. (ICUI) reported $2.16B in revenue for fiscal year 2025. This represents a 8666% increase from $24.6M in 1996.
ICU Medical, Inc. (ICUI) saw revenue decline by 6.4% over the past year.
Yes, ICU Medical, Inc. (ICUI) is profitable, generating $46.3M in net income for fiscal year 2025 (0.0% net margin).
ICU Medical, Inc. (ICUI) has a return on equity (ROE) of 0.0%. This is below average, suggesting room for improvement.
ICU Medical, Inc. (ICUI) generated $80.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
